Two Sigma Investments, LP Clearside Biomedical, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.97 - $1.48 $14,386 - $21,949	-14,831 Reduced 33.33%	29,671 $33,000
Q1 2023 May 15, 2023	SELL	$0.93 - $1.66 $52,384 - $93,502	-56,327 Reduced 55.86%	44,502 $46,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $1.5 $67,374 - $101,061	-67,374 Reduced 40.06%	100,829 $112,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $47,176 - $79,938	-43,682 Reduced 20.62%	168,203 $190,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $159,399 - $305,311	-122,615 Reduced 36.66%	211,885 $311,000
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $817,828 - $1.74 Million	-605,799 Reduced 64.43%	334,500 $766,000
Q4 2021 Feb 14, 2022	BUY	$2.72 - $5.72 $306,816 - $645,216	112,800 Added 13.63%	940,299 $2.59 Million
Q3 2021 Nov 15, 2021	SELL	$4.83 - $7.2 $1.25 Million - $1.86 Million	-257,976 Reduced 23.77%	827,499 $4.97 Million
Q2 2021 Aug 16, 2021	BUY	$2.32 - $5.38 $842,779 - $1.95 Million	363,267 Added 50.3%	1,085,475 $5.29 Million
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $1.28 Million - $2.44 Million	572,969 Added 383.93%	722,208 $1.78 Million
Q4 2020 Feb 16, 2021	SELL	$1.32 - $2.74 $81,197 - $168,545	-61,513 Reduced 29.19%	149,239 $409,000
Q3 2020 Nov 16, 2020	BUY	$1.45 - $2.0 $126,890 - $175,022	87,511 Added 71.01%	210,752 $325,000
Q2 2020 Aug 14, 2020	BUY	$1.55 - $2.41 $191,023 - $297,010	123,241 New	123,241 $232,000
Q3 2019 Nov 14, 2019	SELL	$0.59 - $1.32 $38,846 - $86,911	-65,842 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.97 - $1.42 $1,169 - $1,712	-1,206 Reduced 1.8%	65,842 $64,000
Q1 2019 May 15, 2019	SELL	$1.1 - $1.74 $155,217 - $245,526	-141,107 Reduced 67.79%	67,048 $93,000
Q4 2018 Feb 14, 2019	BUY	$1.0 - $6.12 $113,046 - $691,841	113,046 Added 118.86%	208,155 $223,000
Q3 2018 Nov 14, 2018	BUY	$6.03 - $11.24 $573,507 - $1.07 Million	95,109 New	95,109 $585,000
Q2 2018 Aug 14, 2018	SELL	$8.91 - $14.54 $926,559 - $1.51 Million	-103,991 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $579,229 - $1.48 Million	103,991 New	103,991 $1.12 Million

Others Institutions Holding CLSD

# of Institutions

Shares Held

12.2M

Call Options Held

54.7K

Put Options Held

50.7K

Vanguard Group Inc Valley Forge, PA

2.84M
Shares

$2.47 Million
0.0% of portfolio
Act Capital Management, LLC Wayne, PA

2.2M
Shares

$1.91 Million
3.43% of portfolio
Carmignac Gestion Paris, I0

1.93M
Shares

$1.68 Million
0.04% of portfolio
Black Rock Inc. New York, NY

798K
Shares

$694,379
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

745K
Shares

$648,053
0.0% of portfolio

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account